[HTML][HTML] Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases

AL Cardoso, A Fernandes, JA Aguilar-Pimentel… - Ageing research …, 2018 - Elsevier
Objective Use of the frailty index to measure an accumulation of deficits has been proven a
valuable method for identifying elderly people at risk for increased vulnerability, disease …

Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

MC Lampi, CA Reinhart-King - Science translational medicine, 2018 - science.org
Tissues stiffen during aging and during the pathological progression of cancer, fibrosis, and
cardiovascular disease. Extracellular matrix stiffness is emerging as a prominent mechanical …

Emerging delivery approaches for targeted pulmonary fibrosis treatment

R Diwan, HN Bhatt, E Beaven, M Nurunnabi - Advanced drug delivery …, 2024 - Elsevier
Pulmonary fibrosis (PF) is a progressive, and life-threatening interstitial lung disease which
causes scarring in the lung parenchyma and thereby affects architecture and functioning of …

[HTML][HTML] Transglutaminase 2 has higher affinity for relaxed than for stretched fibronectin fibers

K Selcuk, A Leitner, L Braun, F Le Blanc, P Pacak… - Matrix Biology, 2024 - Elsevier
Abstract Transglutaminase 2 (TG2) plays a vital role in stabilizing extracellular matrix (ECM)
proteins through enzymatic crosslinking during tissue growth, repair, and inflammation. TG2 …

The role of 5-HT metabolism in cancer

D Ye, H Xu, Q Tang, H Xia, C Zhang, F Bi - Biochimica et Biophysica Acta …, 2021 - Elsevier
Abstract Serotonin (5-hydroxytryptamine, 5-HT) metabolism has long been linked to
tumorigenesis and tumor progression. Numerous studies have shown the functions of 5-HT …

[HTML][HTML] Recent advances in cerebral cavernous malformation research

A Padarti, J Zhang - Vessel Plus, 2018 - ncbi.nlm.nih.gov
Cerebral cavernous malformations (CCM) are manifested by microvascular lesions
characterized by leaky endothelial cells with minimal intervening parenchyma …

Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target

RL Eckert - Molecular carcinogenesis, 2019 - Wiley Online Library
Transglutaminase 2 (TG2) has emerged as a key cancer cell survival factor that drives
epithelial to mesenchymal transition, angiogenesis, metastasis, inflammation, drug …

The role of tissue transglutaminase in cancer cell initiation, survival and progression

C Tabolacci, A De Martino, C Mischiati, G Feriotto… - Medical …, 2019 - mdpi.com
Tissue transglutaminase (transglutaminase type 2; TG2) is the most ubiquitously expressed
member of the transglutaminase family (EC 2.3. 2.13) that catalyzes specific post …

Collagen crosslinking: effect on structure, mechanics and fibrosis progression

W Kong, C Lyu, H Liao, Y Du - Biomedical Materials, 2021 - iopscience.iop.org
Biophysical properties of extracellular matrix (ECM), such as matrix stiffness, viscoelasticity
and matrix fibrous structure, are emerging as important factors that regulate progression of …

Cancer-associated fibroblasts in a 3D engineered tissue model induce tumor-like matrix stiffening and EMT transition

M Millet, E Bollmann, C Ringuette Goulet, G Bernard… - Cancers, 2022 - mdpi.com
Simple Summary The physical properties of a tumor, such as stiffness, are important drivers
of tumor progression. However, current in vitro tumor models fail to recapitulate the full range …